Physician profile
Stephen Rice
NPI 1558342808
$8,660.16
in general payments reported to CMS, 2019-2025
20 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $874 · 2021: $781 · 2022: $1,563 · 2023: $1,892 · 2024: $1,198 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,972 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Entertainment: $41.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,971.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Entertainment | $41.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,309.54 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $1,725.70 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,137.57 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $947.07 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Lkc Technologies, INC. | $435.12 | 2022-2025 | |
| Sight Sciences, INC. | $385.82 | 2022-2025 | Tearcare System, Omni Surgical System |
| Alcon Vision LLC | $322.59 | 2020-2023 | Hydrus Microstent |
| Rxsight INC | $196.77 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Sun Pharmaceutical Industries INC. | $180.31 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $180.23 | 2020-2023 | Tecnis Simplicity |
| Maculogix, INC. | $177.40 | 2019-2021 | |
| Optovue, INC. | $171.19 | 2019-2020 | |
| Glaukos Corporation | $106.69 | 2021 | |
| Abbvie INC. | $92.16 | 2024 | |
| Novartis Pharmaceuticals Corporation | $90.85 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $73.16 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $49.11 | 2019 | |
| Heru, INC. | $32.73 | 2022 | |
| Lombart Brothers, INC. | $26.48 | 2023 | Opd-III |
| Allergan, INC. | $19.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.